China
· Delayed Price · Currency is CNY Beijing Wantai Biological Pharmacy Enterprise Statistics
Total Valuation
Beijing Wantai Biological Pharmacy Enterprise has a market cap or net worth of CNY 92.57 billion. The enterprise value is 87.53 billion.
| Market Cap | 92.57B |
| Enterprise Value | 87.53B |
Important Dates
The next estimated earnings date is Tuesday, March 18, 2025.
| Earnings Date | Mar 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Beijing Wantai Biological Pharmacy Enterprise has 1.27 billion shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.27B |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | +8.57% |
| Owned by Insiders (%) | 24.16% |
| Owned by Institutions (%) | 3.67% |
| Float | 253.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 50.51 |
| PS Ratio | 37.15 |
| PB Ratio | 7.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -297.70 |
| EV / Sales | 35.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -572.63 |
Financial Position
The company has a current ratio of 4.61, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.61 |
| Quick Ratio | 4.10 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.82 |
| Interest Coverage | -72.16 |
Financial Efficiency
Return on equity (ROE) is -2.26% and return on invested capital (ROIC) is -1.80%.
| Return on Equity (ROE) | -2.26% |
| Return on Assets (ROA) | -1.54% |
| Return on Capital (ROIC) | -1.80% |
| Revenue Per Employee | 647,931 |
| Profits Per Employee | -76,512 |
| Employee Count | 3,843 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 0.98 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.63% in the last 52 weeks. The beta is 2.20, so Beijing Wantai Biological Pharmacy Enterprise's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | +49.63% |
| 50-Day Moving Average | 72.65 |
| 200-Day Moving Average | 68.76 |
| Relative Strength Index (RSI) | 50.34 |
| Average Volume (20 Days) | 4,738,018 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Wantai Biological Pharmacy Enterprise had revenue of CNY 2.49 billion and -294.04 million in losses. Loss per share was -0.23.
| Revenue | 2.49B |
| Gross Profit | 1.53B |
| Operating Income | -384.61M |
| Pretax Income | -363.22M |
| Net Income | -294.04M |
| EBITDA | -122.77M |
| EBIT | -384.61M |
| Loss Per Share | -0.23 |
Balance Sheet
The company has 5.50 billion in cash and 278.41 million in debt, giving a net cash position of 5.22 billion or 4.13 per share.
| Cash & Cash Equivalents | 5.50B |
| Total Debt | 278.41M |
| Net Cash | 5.22B |
| Net Cash Per Share | 4.13 |
| Equity (Book Value) | 12.61B |
| Book Value Per Share | 9.35 |
| Working Capital | 7.04B |
Cash Flow
In the last 12 months, operating cash flow was 844.54 million and capital expenditures -997.41 million, giving a free cash flow of -152.86 million.
| Operating Cash Flow | 844.54M |
| Capital Expenditures | -997.41M |
| Free Cash Flow | -152.86M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 61.46%, with operating and profit margins of -15.45% and -11.81%.
| Gross Margin | 61.46% |
| Operating Margin | -15.45% |
| Pretax Margin | -14.59% |
| Profit Margin | -11.81% |
| EBITDA Margin | -4.93% |
| EBIT Margin | -15.45% |
| FCF Margin | -6.14% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | -68.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 0.06% |
| Shareholder Yield | 0.50% |
| Earnings Yield | -0.32% |
| FCF Yield | -0.17% |
Stock Splits
The last stock split was on June 5, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 5, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Beijing Wantai Biological Pharmacy Enterprise has an Altman Z-Score of 24.22.
| Altman Z-Score | 24.22 |
| Piotroski F-Score | n/a |